Health Encyclopedia - Test
Factor VII assay
The factor VII assay is a blood test to measure the activity of factor VII. This is one of the substances involved in blood clotting (coagulation).
How the Test is Performed
How to Prepare for the Test
How the Test will Feel
Why the Test is Performed
The normal value is 50 - 200% of the laboratory control or reference value.
Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.
The examples above show the common measurements for results for these tests. Some laboratories use different measurements or may test different specimens.
What Abnormal Results Mean
Decreased factor VII activity may be related to:
Veins and arteries vary in size so it may be harder to take a blood sample from one person than another. Other slight risks from having blood drawn are may include:
- Excessive bleeding
- Fainting or feeling light-headed
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
This test is most often done on people who have bleeding problems. The risk of excessive bleeding is slightly greater than for people without bleeding problems.
When you bleed, the body starts a series of activities that help the blood clot. This is called the coagulation cascade. The process involves special proteins called coagulation factors (factor VII is a coagulation factor).
Each factor's reaction triggers the next reaction. The final product of the coagulation cascade is the blood clot. Blood clots may not form normally if any one of the clotting factors is abnormally low.
Ragni MV. Hemorrhagic Disorders: Coagulation Factor Deficiencies. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 177.
Gailani D, Neff AT. Rare Coagulation Deficiencies. In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz JI, eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, PA: Saunders Elsevier; 2012:chap 139.
Reviewed By: Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Black, Stephanie Slon, and Nissi Wang.